SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director acquired 264 shares of common stock through the vesting of Restricted Stock Units (RSUs), a routine part of their compensation package with no cash value exchanged.
• Market Impact: Neutral. This is a pre-scheduled, non-market transaction with negligible impact on the stock.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	MIGNONE ROBERTO
CIK	0001258394
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-21
Transaction Code	M - Exercise or conversion of derivative security
Security Type	Common Stock
Shares Involved	264
Price Per Share	$0.00
Total Value	$0
Shares Owned After	3,431
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	264
% of Shares Outstanding	Data Not Available
Post-Transaction Ownership	3,431 shares (Ownership % Not Available)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it immaterial against the company's $12.26 billion market capitalization.
• Ownership Concentration: The insider's direct holdings of 3,431 shares are a minor stake. The percentage of total ownership cannot be calculated as shares outstanding data was not provided.
• Dilution Impact: This transaction represents the settlement of previously awarded RSUs and has a negligible dilutive effect.
• Transaction Significance: The filing is administrative, confirming the conversion of RSUs into stock. It is not a discretionary trade and carries no market signal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a non-market, pre-planned transaction related to executive compensation. It does not indicate a change in the insider's sentiment or outlook on the company.

Volume & Sentiment

• Expected Volume Impact: None. The transaction did not occur on the open market.
• Sentiment Indicator: Neutral. The vesting of RSUs is a common and expected event for corporate insiders.

Additional Context

Transaction Notes

• Special Circumstances: The transaction (Code 'M') represents the conversion of Restricted Stock Units into common stock upon vesting. The corresponding derivative transaction shows the disposition of 264 RSUs. As per the footnote, these RSUs are part of a four-year vesting schedule from an award granted in November 2024.